Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims ...

Semaglutide, like tirzepatide, is injected under the skin and is intended ... it to require Novo Nordisk to provide an ...

As obesity rates in the United States soar, insurance companies, including Medicaid and Medicare, are facing financial ...

Drugs and weight loss often go hand in hand, but the journey can feel overwhelming—especially when your wallet takes a hit.

A trial, targeted at people living with obesity from Britain to Puerto Rico, is the first head-to-head comparison of the ...

The company's financial results should remain strong for a while. Analysts expect earnings per share (EPS) to grow at an ...

An Inverness woman is paying more than £200-a-month for medication to treat her Type 2 diabetes because doctors have told her ...

Online health platforms continue to advertise access to copycat versions of blockbuster weight-loss drugs Wegovy and Zepbound ...

Volkswagen board preparing $4.3B cost-savings plan: report. McDonald's confirms beef patties not to blame for E. coli ...

Cheesecake Factory gains after report activist pushing for breakup. Lilly sues companies selling compounded Zepbound, ...

The costs for a similar control group of patients not taking ... The researchers didn't track long-term use of Lilly's newer ...